SEC Form 4 · accession 0001513162-17-000015
Anixa Biosciences Inc · ANIX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).
Reporting owner
John J Monahan
Director
Period of report
Jan 3, 2017
Accepted (ET)
Jan 10, 2017 · 8:15 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000715446
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Options (Right to Buy)F1,F2 | $5.30 | Jan 3, 2017 | A | 12,000 | A | — | Jan 3, 2017 | Common Stock | 12,000 | 12,000 | D |
Explanation of responses
- F1Right-To-Buy, pursuant to the ITUS Corporation 2010 Share Incentive Plan.
- F2options vest and become exercisable in four (4) equal installments on each March 31, 2017, June 30, 2017, September 30, 2017 and December 31, 2017.